Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, China.
School of Life Sciences & Research Center for Peptide Drugs, Yan'an University, Yan'an, Shaanxi, China.
J Biol Chem. 2021 Oct;297(4):101183. doi: 10.1016/j.jbc.2021.101183. Epub 2021 Sep 10.
Sentrin/small ubiquitin-like modifier (SUMO)-specific protease 2 (SENP2)-deficient mice develop spontaneous seizures in early life because of a marked reduction in M currents, which regulate neuronal membrane excitability. We have previously shown that hyper-SUMOylation of the Kv7.2 and Kv7.3 channels is critically involved in the regulation of the M currents conducted by these potassium voltage-gated channels. Here, we show that hyper-SUMOylation of the Kv7.2 and Kv7.3 proteins reduced binding to the lipid secondary messenger PIP. CaM1 has been shown to be tethered to the Kv7 subunits via hydrophobic motifs in its C termini and implicated in the channel assembly. Mutation of the SUMOylation sites on Kv7.2 and Kv7.3 specifically resulted in decreased binding to CaM1 and enhanced CaM1-mediated assembly of Kv7.2 and Kv7.3, whereas hyper-SUMOylation of Kv7.2 and Kv7.3 inhibited channel assembly. SENP2-deficient mice exhibited increased acetylcholine levels in the brain and the heart tissue because of increases in the vagal tone induced by recurrent seizures. The SENP2-deficient mice develop seizures followed by a period of sinus pauses or atrioventricular conduction blocks. Chronic administration of the parasympathetic blocker atropine or unilateral vagotomy significantly prolonged the life of the SENP2-deficient mice. Furthermore, we showed that retigabine, an M-current opener, reduced the transcription of SUMO-activating enzyme SAE1 and inhibited SUMOylation of the Kv7.2 and Kv7.3 channels, and also prolonged the life of SENP2-deficient mice. Taken together, the previously demonstrated roles of PIP2, CaM1, and retigabine on the regulation of Kv7.2 and Kv7.3 channel function can be explained by their roles in regulating SUMOylation of this critical potassium channel.
SENP2 缺陷型小鼠在生命早期会自发发生癫痫发作,因为 M 电流显著减少,而 M 电流调节神经元膜兴奋性。我们之前已经表明,Kv7.2 和 Kv7.3 通道的超 SUMO 化在调节这些钾电压门控通道传导的 M 电流中起着至关重要的作用。在这里,我们表明 Kv7.2 和 Kv7.3 蛋白的超 SUMO 化降低了与脂质第二信使 PIP 的结合。已经表明 CaM1 通过其 C 末端的疏水性基序与 Kv7 亚基连接,并参与通道组装。Kv7.2 和 Kv7.3 上 SUMO 化位点的突变特异性导致与 CaM1 的结合减少,并增强 CaM1 介导的 Kv7.2 和 Kv7.3 的组装,而 Kv7.2 和 Kv7.3 的超 SUMO 化抑制了通道组装。由于反复癫痫发作引起的迷走神经张力增加,SENP2 缺陷型小鼠的大脑和心脏组织中的乙酰胆碱水平升高。SENP2 缺陷型小鼠会发生癫痫发作,随后会出现窦性暂停或房室传导阻滞。慢性给予副交感神经阻滞剂阿托品或单侧迷走神经切断术可显著延长 SENP2 缺陷型小鼠的寿命。此外,我们表明,M 电流开放剂 retigabine 降低 SUMO 激活酶 SAE1 的转录并抑制 Kv7.2 和 Kv7.3 通道的 SUMO 化,并且还延长了 SENP2 缺陷型小鼠的寿命。综上所述,先前已经证明 PIP2、CaM1 和 retigabine 在调节 Kv7.2 和 Kv7.3 通道功能中的作用可以通过它们在调节这种关键钾通道的 SUMO 化中的作用来解释。